Full Details & Current Designation List - Short-Selling Restriction Rule Change in Korea
It is now official that we have a new short-selling restriction rule, which is effective as of March 11. For the existing regulations, we now have...
551 Views
SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing
SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...
3.6k Views
DNA Synthesis with a Silicon Twist
Twist's fast, cheap DNA synthesis will power biotech start-ups, driving demand, fostering loyalty, enabling innovation, and securing new and...
412 Views
Smartkarma Originals
Asian Healthcare - Coming of Age
This Smartkarma Originals Insight highlights 20 leading unlisted healthcare companies in Asia, mainly in digital healthcare and biopharma, that are...
1.1k Views
CV Note:Â Macrogen (038290 KQ)
"Korea’s #1 and the world’s #5 NGS player" The world’s 5th ranked DNA sequencing service provider. Growing NGS (Next Generation Sequencing) market...
718 Views